10/27/2020BioPlan - Biologics Manufacturing In China: Competition Heats Up Among...

10/27/2020China Publishes Anti-Monopoly Guidelines on Intellectual Property

10/23/2020Amgen's China Strategy Forward: Collaborating with Local Partners on W...

10/23/2020China Signs Off on PRC Biosecurity Law: What This Means for Industry P...

10/23/2020Recent Executive Moves

10/22/2020Priority Review Granted to Ascentage Pharma's NDA for Olverembatinib (...

10/22/2020CDE Issues the Guidance for Acceptance and Evaluation of TCMs

10/22/2020COHGRM Issues Notice on Further Optimizing the Administrative Approval...

10/22/2020Nation's Healthcare Expands to Cover All Urban and Rural areas

10/21/2020Fujifilm and Carelink Form Partnership Seeking Chinese Approval of Avi...

10/20/2020Roche Experiences China Growth Hiccup amid Pandemic and Price Cuts

10/20/2020How COVID-19 Poses a Sharp Challenge on China Biopharma Contract Manuf...

10/19/2020NHSA Launches Trial for Regional Point-based Global Budget and Big Dat...

10/19/2020Immunogen and Huadong Medicine Enter Strategic Deal for Mirvetuximab ...

10/18/2020118 Domestically-Listed MedPharm Cos Disclose Their Q3/2020 Performanc...

10/16/2020Daiichi Sankyo Submits IND Application for ADC Medicine Enhertu (DS-82...

10/16/2020Recent Executive Moves

10/15/2020AffaMed Therapeutics merging with EverInsight

10/15/2020NeoGenomics to Expand Pharma Services in China

10/15/2020Eisai's sNDAs for Anti-Epileptic Drug Fycompa Accepted in China

10/14/2020Hainan Announces First QFLP Fund, Insurance to Cover Foreign Anti-Canc...

10/13/2020Overview of China's Internet-Based Medicine

10/13/2020KBR: Medytox Suspected of Illegally Selling BTX in China

10/13/2020Rhizen Pharma and Curon Biopharma Enter License Deal for Tenalisib in ...

10/13/2020China: BMI Fund Cannot Afford to Cover Vaccinations

10/13/2020SAMR Solicits Comments on the Draft Guide to Antimonopoly in the Bulk ...

10/12/2020CDE Issues the Clinical Requirements for Drugs Marketed Outside China ...

10/11/2020Antengene Announces Collaboration with WuXi Biologics to Advance the D...

10/10/2020Innovent and Lilly Announce the NMPA Approval of HALPRYZA® (Rituximab...

10/10/2020NHSA and MOF Issues Joint Notice to Advance the Trial for Inter-Provin...

Page:108/360 Total number of articles:10786: [First][<<] [106] [107] [108] [109] [110] [>>] [End]